Some countries have excelled in the face of the Covid-19 pandemic, but most haven't, and
whether it comes to the lockdown being excessive or inadequate, the supply of personal protective
equipment or the lack of reliable testing, and with an effective vaccine months or even years away,
there is a very clear message concerning the essential-indeed, unique-benefits of consumer healthcare.
Our current forecast for 2020 shows that purchases of consumer healthcare products in the retail sector
will increase by X.X% in constant currency this year vs X.X% last year, which is a good achievement
bearing in mind the devastation of the economy and disruption of infrastructure.
For marketers, the pandemic is presenting opportunities as well as challenges, and we expect to see long-term changes in
consumer behaviour as a result of the virus. This includes a deepened interest in wellness and immunity, as well as an increased
focus on sanitation and hygiene.
Why buy this report?
"The all-new 2nd edition of this special Hot Topic review from Nicholas Hall's CIMA (Competitive Intelligence & Market Analysis) division explores the response to the pandemic from CHC brands and marketers as well as the overall impact on CHC to date."
Table of Contents
Introduction from Nicholas Hall
CHC Market Impact
- Sales peak in Q1
- Changing consumer behaviour
- Online price rises
- Online sales growth
Response of key CHC players
- Performance in Q1
- Exceptional demand
CHC Market Benchmarks
- How does CHC fare in turbulent times?
- Historical viral outbreaks:
SARS 2003, Swine flu 2009
CHC Market Projections
- Most likely scenario
- Best & worst case scenario (Retail channel)
- Economic Impact
CHC Category Impact
- Antiseptics & Disinfectants
- Cough, Cold & Allergy
- Vitamins, Minerals & Supplements
- Sleep Aids
- OTC Antivirals
- Face Masks
CHC Regulatory Impact:
Relaxation of Regulations
Distribution: Impact on consumer
- Industry response
- Brand A+P response